低体温療法装置の世界市場予測(~2028):製品別、用途別、地域別

■ 英語タイトル:Therapeutic Hypothermia Systems Market by Product (Cooling Devices, Cooling Catheters, Cool Caps), Application (Neurology, Cardiology, Neonatal Care), and Region (North America, Europe, Asia- Pacific, RoW) - Global Forecast to 2028

調査会社MarketsandMarkets社が発行したリサーチレポート(データ管理コード:MD8924-24)■ 発行会社/調査会社:MarketsandMarkets
■ 商品コード:MD8924-24
■ 発行日:2024年1月19日
■ 調査対象地域:グローバル
■ 産業分野:医療機器
■ ページ数:168
■ レポート言語:英語
■ レポート形式:PDF
■ 納品方式:Eメール(受注後24時間以内)
■ 販売価格オプション(消費税別)
Single User(1名様閲覧)USD4,950 ⇒換算¥732,600見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥984,200見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥1,206,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行・送付致します。(請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能)
MarketsandMarkets社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[低体温療法装置の世界市場予測(~2028):製品別、用途別、地域別]についてメールでお問い合わせはこちら
*** レポート概要(サマリー)***

“低体温療法装置の世界市場は、2023年の291百万米ドルから2028年には396百万米ドルに達すると予測され、予測期間中の年平均成長率は6.3%”この市場の成長の主な原動力は、感染症や慢性疾患の有病率の増加と、低侵襲的な冷却方法の使用の増加です。しかし、代替方法の存在や発展途上国における認知度の低さが、低体温療法装置市場の成長を抑制する可能性があります。

“予測期間中、低体温療法装置市場において製品別で最も高い市場シェアを占めた冷却装置セグメント”
製品別に見ると、低体温療法装置市場は冷却カテーテル、冷却デバイス、クールキャップに分類されます。2022年には冷却装置セグメントが市場をリードしました。このセグメントの大きなシェアは、使いやすさ、利用可能な労働集約的なデバイスの少なさ、制御ユニットによるシンプルで効果的な温度調整システムの存在によるものです。

“予測期間中のCAGRが最も高かったのは心臓病学”
用途に基づき、低体温療法装置市場は神経学、心臓病学、新生児医療、その他の用途に細分化されています。2022年の低体温療法装置市場のCAGRが最も高いのは心臓病学分野でした。このセグメントのCAGRが最も高いのは、主に心停止患者の治療に低体温療法を使用する潜在的なメリットがあるためです。

“予測期間中、地域別では北米セグメントが低体温療法装置市場で最も高い市場シェアを占める”
地域別に見ると、世界の低体温療法装置市場は、北米、アジア太平洋、ヨーロッパ、その他の地域に分類されます。北米は予測期間中に高い市場シェアが見込まれます。技術的に高度な低体温療法装置製品の存在と医療機器産業における進歩の増加が、低体温療法装置市場の成長を支えています。

供給側一次インタビューの企業タイプ別、役職別、地域別内訳は以下の通りです:

- 企業タイプ別 ティア1(30%)、ティア2(48%)、ティア3(22)
- 役職別 Cレベル(28%)、ディレクターレベル(33%)、その他(39%)
- 地域別 北米 (21%)、ヨーロッパ (30%)、アジア太平洋 (34%)、その他地域(15%)

主な企業には、ZOLL Medical Corporation (Japan), Becton, Dickinson and Company (US), Stryker Corporation (US), Gentherm Incorporated (US), Belmont Medical Technologies (US), International Biomedical Ltd. (US), EM-MED (Poland), Phoenix Medical Systems (India), Life Recovery Systems (US), Shenzhen Comen Medical Instruments Co., Ltd. (China), MiraCradle (India), Terumo Cardiovascular Systems Corporation (US), pfm medical hico gmbh (Germany), VNG Medical Innovation System Pvt. Ltd. (India), Aspen Systems (US), CoolTech Medical (US), Global Healthcare SG (Singapore), Cryothermic Systems Incorporated (US), Paxman Coolers Ltd. (UK), Dignitana AB (Italy), and Wishcaps (US)などが挙げられます。

調査範囲

この調査レポートは、低体温療法装置市場を製品、用途、地域別に分類しています。低体温療法装置市場の成長に影響を与える促進要因、阻害要因、課題、機会などの主要要因に関する詳細情報を網羅しています。主要な業界プレイヤーを詳細に分析し、事業概要、ソリューション、サービス、主要戦略、契約、パートナーシップ、合意などに関する洞察を提供します。低体温療法装置市場に関連する新製品・サービスの発売、合併・買収、最近の動向を記載しています。低体温療法装置市場のエコシステムにおける今後の新興企業の競争分析もカバーしています。

レポート購入の主な利点

本レポートは、低体温療法装置市場全体およびサブセグメントの収益数の最も近い近似値に関する情報を提供することで、本市場の市場リーダー/新規参入者に役立ちます。本レポートは、利害関係者が競争状況を理解し、自社のビジネスをより良く位置づけ、適切な市場参入戦略を計画するためのより多くの洞察を得るのに役立ちます。また、当レポートは、関係者が市場の鼓動を理解するのに役立ち、主要な市場促進要因、阻害要因、課題、機会に関する情報を提供します。

本レポートは、以下のポイントに関する洞察を提供します:

- 低体温療法装置市場の成長に影響を与える主な促進要因、阻害要因、機会、課題の分析しました。
- 製品開発/イノベーション: 低体温療法装置市場における今後の技術、研究開発活動、新製品・新サービスの発表に関する詳細な洞察を提供します。
- 市場開発: 有利な市場に関する包括的な情報 - 当レポートでは、さまざまな地域の低体温療法装置市場を分析しています。
- 市場の多様化: 低体温療法装置市場における新製品、未開拓地域、最近の開発、投資に関する詳細情報を記載しています。
- 競合評価: ZOLL Medical Corporation (日本)、Becton, Dickinson and Company (アメリカ)、Stryker Corporation (アメリカ)などの主要企業の低体温療法装置市場戦略における市場ランキング、成長戦略、サービス提供などを詳細に評価しています。

1. 序論
2. 調査方法
3. エグゼクティブサマリー
4. プレミアムインサイト
5. 市場概要
6. 世界の低体温療法装置市場規模:製品別
7. 世界の低体温療法装置市場規模:用途別
8. 世界の低体温療法装置市場規模:地域別
9. 競争状況
10. 企業情報
11. 付録

*** レポート目次(コンテンツ)***

1 INTRODUCTION 25
1.1 STUDY OBJECTIVES 25
1.2 MARKET DEFINITION 25
1.2.1 INCLUSIONS & EXCLUSIONS OF STUDY 26
1.3 MARKET SCOPE 26
1.3.1 MARKETS COVERED 26
FIGURE 1 THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SEGMENTATION 26
1.3.2 YEARS CONSIDERED 27
1.4 CURRENCY 27
1.5 STAKEHOLDERS 27
1.6 LIMITATIONS 28
2 RESEARCH METHODOLOGY 29
2.1 RESEARCH DATA 29
FIGURE 2 RESEARCH DESIGN 29
2.1.1 SECONDARY DATA 30
2.1.1.1 Secondary sources 30
2.1.2 PRIMARY DATA 31
FIGURE 3 PRIMARY SOURCES 31
2.1.2.1 Key data from primary sources 32
2.1.2.2 Key industry insights 32
2.1.2.3 Breakdown of primary interviews 33
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 33
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: BY END USER, DESIGNATION, AND REGION 33
2.2 MARKET SIZE ESTIMATION 34
2.2.1 APPROACH 1: COMPANY REVENUE ESTIMATION APPROACH 34
FIGURE 6 BOTTOM-UP APPROACH: COMPANY REVENUE ESTIMATION 34
2.2.2 APPROACH 2: NUMBER OF THERAPEUTIC HYPOTHERMIA SYSTEMS 35
TABLE 1 REVENUE ESTIMATION APPROACH BY CALCULATING MARKET SIZE OF THERAPEUTIC HYPOTHERMIA SYSTEMS 35
2.2.3 APPROACH 3: PRESENTATIONS OF COMPANIES AND PRIMARY INTERVIEWS 35
2.2.4 APPROACH 4: PRIMARY INTERVIEWS 36
FIGURE 7 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 36
FIGURE 8 TOP-DOWN APPROACH 37
2.3 MARKET BREAKDOWN & DATA TRIANGULATION 38
FIGURE 9 DATA TRIANGULATION METHODOLOGY 38
2.4 MARKET SHARE ANALYSIS 39
2.5 MARKET ASSUMPTIONS 39
2.6 RISK ASSESSMENT 39
TABLE 2 RISK ASSESSMENT 39
2.7 RECESSION IMPACT ON THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET 40
3 EXECUTIVE SUMMARY 41
FIGURE 10 THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY PRODUCT, 2023 VS. 2028 (USD MILLION) 41
FIGURE 11 THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION) 42
FIGURE 12 GEOGRAPHICAL SNAPSHOT OF THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET 42
4 PREMIUM INSIGHTS 44
4.1 THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET OVERVIEW 44
FIGURE 13 RISING NUMBER OF SURGICAL PROCEDURES TO DRIVE THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET 44
4.2 ASIA PACIFIC: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY PRODUCT AND COUNTRY (2022) 45
FIGURE 14 COOLING DEVICES SEGMENT ACCOUNTED FOR LARGEST SHARE OF ASIA PACIFIC MARKET IN 2022 45
4.3 THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 46
FIGURE 15 CHINA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD 46
4.4 THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET: REGIONAL MIX 46
FIGURE 16 ASIA PACIFIC MARKET TO WITNESS FASTEST GROWTH DURING FORECAST PERIOD 46
4.5 THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET: DEVELOPED VS. EMERGING ECONOMIES 47
FIGURE 17 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH DURING FORECAST PERIOD 47
5 MARKET OVERVIEW 48
5.1 INTRODUCTION 48
5.2 MARKET DYNAMICS 48
FIGURE 18 THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 48
5.2.1 DRIVERS 49
5.2.1.1 Rising population and increasing prevalence of chronic and infectious diseases 49
5.2.1.2 Increasing number of surgical procedures 49
5.2.1.3 Rising number of hypothermia cases 50
5.2.1.4 Growing number of trauma cases 50
5.2.1.5 Rising adoption of minimally invasive cooling methods 51
5.2.1.6 Growing demand for targeted temperature management in cardiac arrest 51
5.2.2 RESTRAINTS 51
5.2.2.1 Lack of awareness regarding therapeutic hypothermia systems in developing countries 51
5.2.2.2 Availability of alternative methods 52
5.2.3 OPPORTUNITIES 52
5.2.3.1 Increasing growth opportunities in emerging economies 52
5.2.3.2 Developing healthcare infrastructure 53
5.2.3.3 Growing number of contracts and agreements between market players 53
5.2.4 CHALLENGES 54
5.2.4.1 Lack of skilled healthcare professionals 54
5.2.4.2 Lack of proper supply chain management 54
5.2.4.3 Product recalls 55
5.3 VALUE CHAIN ANALYSIS 55
FIGURE 19 VALUE CHAIN ANALYSIS: MAXIMUM VALUE ADDED DURING MANUFACTURING PHASE 55
5.4 SUPPLY CHAIN ANALYSIS 56
FIGURE 20 DISTRIBUTION—STRATEGY PREFERRED BY PROMINENT COMPANIES 57
5.5 PORTER’S FIVE FORCES ANALYSIS 57
TABLE 3 PORTER’S FIVE FORCES ANALYSIS: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET 57
5.5.1 INTENSITY OF COMPETITIVE RIVALRY 57
5.5.2 BARGAINING POWER OF SUPPLIERS 57
5.5.3 BARGAINING POWER OF BUYERS 58
5.5.4 THREAT OF SUBSTITUTES 58
5.5.5 THREAT OF NEW ENTRANTS 58
5.6 REGULATORY ANALYSIS 58
TABLE 4 INDICATIVE LIST OF REGULATORY AUTHORITIES GOVERNING THERAPEUTIC HYPOTHERMIA SYSTEMS 58
5.6.1 NORTH AMERICA 59
5.6.1.1 US 59
TABLE 5 CLASSIFICATION OF MEDICAL DEVICES BY US FDA 59
FIGURE 21 PREMARKET NOTIFICATION: 510(K) APPROVAL FOR MEDICAL DEVICES 60
5.6.1.2 Canada 60
FIGURE 22 CANADA: APPROVAL PROCESS FOR MEDICAL DEVICES 60
5.6.2 EUROPE 61
FIGURE 23 CE APPROVAL PROCESS FOR THERAPEUTIC HYPOTHERMIA SYSTEMS 61
5.6.3 ASIA PACIFIC 61
5.6.3.1 Japan 61
TABLE 6 JAPAN: CLASSIFICATION OF MEDICAL DEVICES 62
5.6.3.2 China 62
TABLE 7 NMPA MEDICAL DEVICES CLASSIFICATION 62
5.6.3.3 India 63
5.7 TRADE ANALYSIS 63
5.7.1 TRADE ANALYSIS FOR THERAPEUTIC HYPOTHERMIA SYSTEMS 63
TABLE 8 IMPORT DATA FOR HS CODE 901890, BY COUNTRY, 2018–2022 (USD MILLION) 63
TABLE 9 EXPORT DATA FOR HS CODE 901890, BY COUNTRY, 2018–2022 (USD MILLION) 63
5.8 TECHNOLOGY ANALYSIS 64
5.9 ECOSYSTEM ANALYSIS 65
FIGURE 24 THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET: ECOSYSTEM ANALYSIS 65
5.9.1 ROLE IN ECOSYSTEM 65
FIGURE 25 KEY PLAYERS IN THERAPEUTIC HYPOTHERMIA SYSTEMS ECOSYSTEM 66
5.10 PATENT ANALYSIS 67
FIGURE 26 PATENT ANALYSIS FOR THERAPEUTIC HYPOTHERMIA SYSTEMS 67
5.11 KEY CONFERENCES AND EVENTS IN 2024–2025 68
TABLE 10 LIST OF CONFERENCES AND EVENTS IN 2024–2025 68
5.12 PRICING ANALYSIS 70
TABLE 11 AVERAGE SELLING PRICE OF KEY PRODUCTS IN THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET (2019–2022) 70
TABLE 12 AVERAGE SELLING PRICE TRENDS, BY REGION, 2019–2022 70
5.13 TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS 71
5.13.1 REVENUE SHIFT & REVENUE POCKETS FOR THERAPEUTIC HYPOTHERMIA SYSTEM MANUFACTURERS 71
FIGURE 27 REVENUE SHIFT FOR THERAPEUTIC HYPOTHERMIA SYSTEMS 71
5.14 KEY STAKEHOLDERS AND BUYING CRITERIA 72
5.14.1 KEY STAKEHOLDERS IN BUYING PROCESS 72
FIGURE 28 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR HOSPITALS 72
TABLE 13 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR HOSPITALS 72
5.14.2 BUYING CRITERIA 73
FIGURE 29 KEY BUYING CRITERIA FOR TOP END USERS 73
TABLE 14 KEY BUYING CRITERIA, BY TOP END USER 73
6 THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY PRODUCT 74
6.1 INTRODUCTION 75
TABLE 15 THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 75
6.2 COOLING DEVICES 75
6.2.1 INCREASING PREVALENCE OF CARDIOVASCULAR DISEASES TO DRIVE DEMAND 75
TABLE 16 THERAPEUTIC HYPOTHERMIA COOLING DEVICES MARKET, BY REGION, 2021–2028 (USD MILLION) 76
TABLE 17 NORTH AMERICA: THERAPEUTIC HYPOTHERMIA COOLING DEVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 76
TABLE 18 EUROPE: THERAPEUTIC HYPOTHERMIA COOLING DEVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 77
TABLE 19 ASIA PACIFIC: THERAPEUTIC HYPOTHERMIA COOLING DEVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 77
TABLE 20 REST OF THE WORLD: THERAPEUTIC HYPOTHERMIA COOLING DEVICES MARKET, BY REGION, 2021–2028 (USD MILLION) 78
6.3 COOLING CATHETERS 78
6.3.1 ABILITY TO COOL SPECIFIC AREAS EFFICIENTLY TO SUPPORT MARKET GROWTH 78
TABLE 21 THERAPEUTIC HYPOTHERMIA COOLING CATHETERS MARKET, BY REGION, 2021–2028 (USD MILLION) 78
TABLE 22 NORTH AMERICA: THERAPEUTIC HYPOTHERMIA COOLING CATHETERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 79
TABLE 23 EUROPE: THERAPEUTIC HYPOTHERMIA COOLING CATHETERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 79
TABLE 24 ASIA PACIFIC: THERAPEUTIC HYPOTHERMIA COOLING CATHETERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 80
TABLE 25 REST OF THE WORLD: THERAPEUTIC HYPOTHERMIA COOLING CATHETERS MARKET, BY REGION, 2021–2028 (USD MILLION) 80
6.4 COOL CAPS 80
6.4.1 INCREASING NUMBER OF CHEMOTHERAPY PROCEDURES TO DRIVE DEMAND 80
TABLE 26 THERAPEUTIC HYPOTHERMIA COOL CAPS MARKET, BY REGION, 2021–2028 (USD MILLION) 81
TABLE 27 NORTH AMERICA: THERAPEUTIC HYPOTHERMIA COOL CAPS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 81
TABLE 28 EUROPE: THERAPEUTIC HYPOTHERMIA COOL CAPS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 82
TABLE 29 ASIA PACIFIC: THERAPEUTIC HYPOTHERMIA COOL CAPS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 82
TABLE 30 REST OF THE WORLD: THERAPEUTIC HYPOTHERMIA COOL CAPS MARKET, BY REGION, 2021–2028 (USD MILLION) 83
7 THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY APPLICATION 84
7.1 INTRODUCTION 85
TABLE 31 THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 85
7.2 NEUROLOGY 85
7.2.1 GROWING PREVALENCE OF TBI AND OTHER NEUROLOGICAL DISEASES TO DRIVE MARKET 85
TABLE 32 THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET FOR NEUROLOGY, BY REGION, 2021–2028 (USD MILLION) 86
TABLE 33 NORTH AMERICA: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET FOR NEUROLOGY, BY COUNTRY, 2021–2028 (USD MILLION) 86
TABLE 34 EUROPE: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET FOR NEUROLOGY, BY COUNTRY, 2021–2028 (USD MILLION) 86
TABLE 35 ASIA PACIFIC: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET FOR NEUROLOGY, BY COUNTRY, 2021–2028 (USD MILLION) 87
TABLE 36 REST OF THE WORLD: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET FOR NEUROLOGY, BY REGION, 2021–2028 (USD MILLION) 87
7.3 CARDIOLOGY 87
7.3.1 HIGH INCIDENCE OF CARDIAC ARRESTS TO SUPPORT MARKET GROWTH 87
TABLE 37 THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET FOR CARDIOLOGY, BY REGION, 2021–2028 (USD MILLION) 88
TABLE 38 NORTH AMERICA: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET FOR CARDIOLOGY, BY COUNTRY, 2021–2028 (USD MILLION) 88
TABLE 39 EUROPE: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET FOR CARDIOLOGY, BY COUNTRY, 2021–2028 (USD MILLION) 89
TABLE 40 ASIA PACIFIC: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET FOR CARDIOLOGY, BY COUNTRY, 2021–2028 (USD MILLION) 89
TABLE 41 REST OF THE WORLD: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET FOR CARDIOLOGY, BY REGION, 2021–2028 (USD MILLION) 90
7.4 NEONATAL CARE 90
7.4.1 INCREASING NUMBER OF PRETERM BIRTHS TO SUPPORT MARKET GROWTH 90
TABLE 42 THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET FOR NEONATAL CARE, BY REGION, 2021–2028 (USD MILLION) 91
TABLE 43 NORTH AMERICA: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET FOR NEONATAL CARE, BY COUNTRY, 2021–2028 (USD MILLION) 91
TABLE 44 EUROPE: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET FOR NEONATAL CARE, BY COUNTRY, 2021–2028 (USD MILLION) 91
TABLE 45 ASIA PACIFIC: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET FOR NEONATAL CARE, BY COUNTRY, 2021–2028 (USD MILLION) 92
TABLE 46 REST OF THE WORLD: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET FOR NEONATAL CARE, BY REGION, 2021–2028 (USD MILLION) 92
7.5 OTHER APPLICATIONS 92
TABLE 47 THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET FOR OTHER APPLICATIONS, BY REGION, 2021–2028 (USD MILLION) 93
TABLE 48 NORTH AMERICA: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 93
TABLE 49 EUROPE: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 94
TABLE 50 ASIA PACIFIC: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 94
TABLE 51 REST OF THE WORLD: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET FOR OTHER APPLICATIONS, BY REGION, 2021–2028 (USD MILLION) 95
8 THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY REGION 96
8.1 INTRODUCTION 97
TABLE 52 THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY REGION, 2021–2028 (USD MILLION) 97
8.2 NORTH AMERICA 98
FIGURE 30 NORTH AMERICA: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SNAPSHOT 98
8.2.1 NORTH AMERICA: RECESSION IMPACT 99
TABLE 53 NORTH AMERICA: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 99
TABLE 54 NORTH AMERICA: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 99
TABLE 55 NORTH AMERICA: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 100
8.2.2 US 100
8.2.2.1 Growing number of cardiac arrest and brain injury cases to support market growth 100
TABLE 56 US: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 101
TABLE 57 US: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 101
TABLE 58 US: THERAPEUTIC HYPOTHERMIA COOLING DEVICES MARKET, BY VOLUME, 2021–2028 (THOUSAND UNITS) 102
8.2.3 CANADA 102
8.2.3.1 Increasing incidence of various chronic diseases to drive market 102
TABLE 59 CANADA: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 103
TABLE 60 CANADA: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 103
8.3 EUROPE 104
8.3.1 EUROPE: RECESSION IMPACT 104
TABLE 61 EUROPE: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 104
TABLE 62 EUROPE: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 105
TABLE 63 EUROPE: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 105
8.3.2 GERMANY 105
8.3.2.1 High demand for patient cooling devices for cardiology procedures to drive market 105
TABLE 64 GERMANY: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 106
TABLE 65 GERMANY: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 106
TABLE 66 GERMANY: THERAPEUTIC HYPOTHERMIA COOLING DEVICES MARKET, BY VOLUME, 2021–2028 (THOUSAND UNITS) 106
8.3.3 UK 107
8.3.3.1 Rising number of sports injuries and accident & emergency procedures to drive market 107
TABLE 67 UK: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 107
TABLE 68 UK: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 108
TABLE 69 UK: THERAPEUTIC HYPOTHERMIA COOLING DEVICES MARKET, BY VOLUME, 2021–2028 (THOUSAND UNITS) 108
8.3.4 FRANCE 108
8.3.4.1 Strong healthcare system to support market growth 108
TABLE 70 FRANCE: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 109
TABLE 71 FRANCE: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 109
TABLE 72 FRANCE: THERAPEUTIC HYPOTHERMIA COOLING DEVICES MARKET, BY VOLUME, 2021–2028 (THOUSAND UNITS) 110
8.3.5 ITALY 110
8.3.5.1 Growing demand for therapeutic hypothermia systems in traumatic brain injury treatment to support market growth 110
TABLE 73 ITALY: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 110
TABLE 74 ITALY: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 111
8.3.6 SPAIN 111
8.3.6.1 Growing geriatric population and subsequent increase in prevalence of target conditions to drive market 111
TABLE 75 SPAIN: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 112
TABLE 76 SPAIN: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 112
8.3.7 REST OF EUROPE 112
TABLE 77 REST OF EUROPE: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 113
TABLE 78 REST OF EUROPE: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 113
8.4 ASIA PACIFIC 114
FIGURE 31 ASIA PACIFIC: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SNAPSHOT 114
8.4.1 ASIA PACIFIC: RECESSION IMPACT 115
TABLE 79 ASIA PACIFIC: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 115
TABLE 80 ASIA PACIFIC: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 115
TABLE 81 ASIA PACIFIC: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 116
8.4.2 CHINA 116
8.4.2.1 Increasing disposable income of middle-class population to drive market 116
TABLE 82 CHINA: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 117
TABLE 83 CHINA: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 117
TABLE 84 CHINA: THERAPEUTIC HYPOTHERMIA COOLING DEVICES MARKET, BY VOLUME, 2021–2028 (THOUSAND UNITS) 117
8.4.3 JAPAN 118
8.4.3.1 Rapidly increasing geriatric population to drive market 118
TABLE 85 JAPAN: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 118
TABLE 86 JAPAN: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 119
TABLE 87 JAPAN: THERAPEUTIC HYPOTHERMIA COOLING DEVICES MARKET, BY VOLUME, 2021–2028 (THOUSAND UNITS) 119
8.4.4 INDIA 119
8.4.4.1 Growing target patient population to support market growth 119
TABLE 88 INDIA: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 120
TABLE 89 INDIA: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 120
8.4.5 REST OF ASIA PACIFIC 120
TABLE 90 REST OF ASIA PACIFIC: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 121
TABLE 91 REST OF ASIA PACIFIC: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 122
8.5 REST OF THE WORLD 122
8.5.1 REST OF THE WORLD: RECESSION IMPACT 122
TABLE 92 REST OF THE WORLD: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY REGION, 2021–2028 (USD MILLION) 123
TABLE 93 REST OF THE WORLD: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 123
TABLE 94 REST OF THE WORLD: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 123
8.5.2 LATIN AMERICA 124
8.5.2.1 Rising prevalence of chronic diseases to drive market 124
TABLE 95 LATIN AMERICA: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 124
TABLE 96 LATIN AMERICA: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 125
8.5.3 MIDDLE EAST & AFRICA 125
8.5.3.1 High prevalence of chronic conditions to support market growth 125
TABLE 97 MIDDLE EAST & AFRICA: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 125
TABLE 98 MIDDLE EAST & AFRICA: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 126
8.5.4 GCC COUNTRIES 126
8.5.4.1 Rise in road accident injuries and TBI to drive market 126
TABLE 99 GCC COUNTRIES: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 126
TABLE 100 GCC COUNTRIES: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 127
9 COMPETITIVE LANDSCAPE 128
9.1 OVERVIEW 128
9.2 STRATEGIES ADOPTED BY KEY PLAYERS 128
TABLE 101 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET 128
9.3 REVENUE ANALYSIS 129
FIGURE 32 REVENUE ANALYSIS FOR KEY COMPANIES IN THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, 2018–2022 (USD MILLION) 129
9.4 MARKET SHARE ANALYSIS 130
FIGURE 33 THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET RANKING ANALYSIS, BY KEY PLAYER (2022) 130
TABLE 102 THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET: DEGREE OF COMPETITION 130
9.5 COMPANY EVALUATION MATRIX 131
9.5.1 STARS 131
9.5.2 EMERGING LEADERS 131
9.5.3 PERVASIVE PLAYERS 131
9.5.4 PARTICIPANTS 131
FIGURE 34 THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET: COMPANY EVALUATION MATRIX, 2022 132
9.5.5 COMPANY FOOTPRINT 133
TABLE 103 PRODUCT FOOTPRINT (11 PLAYERS) 133
TABLE 104 REGIONAL FOOTPRINT (11 PLAYERS) 133
TABLE 105 OVERALL COMPANY FOOTPRINT (11 PLAYERS) 134
9.6 STARTUP/SME EVALUATION MATRIX 135
9.6.1 PROGRESSIVE COMPANIES 135
9.6.2 STARTING BLOCKS 135
9.6.3 RESPONSIVE COMPANIES 135
9.6.4 DYNAMIC COMPANIES 135
FIGURE 35 THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET: STARTUP/SME EVALUATION MATRIX, 2022 136
9.6.5 COMPETITIVE BENCHMARKING 137
TABLE 106 THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET: DETAILED LIST OF KEY STARTUPS/SMES 137
TABLE 107 PRODUCT & SERVICE FOOTPRINT (STARTUPS/SMES) 137
TABLE 108 REGIONAL FOOTPRINT (STARTUPS/SMES) 138
TABLE 109 OVERALL COMPANY FOOTPRINT (STARTUPS/SMES) 138
9.7 COMPETITIVE SCENARIO AND TRENDS 139
9.7.1 DEALS 139
TABLE 110 THERAPEUTIC HYPOTHERMIA SYSTEMS: DEALS, JANUARY 2020–NOVEMBER 2023 139
9.7.2 OTHER DEVELOPMENTS 140
TABLE 111 THERAPEUTIC HYPOTHERMIA SYSTEMS: OTHER DEVELOPMENTS, JANUARY 2020–NOVEMBER 2023 140
10 COMPANY PROFILES 141
10.1 KEY PLAYERS 141
(Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments)*
10.1.1 ASAHI KASEI CORPORATION (ZOLL MEDICAL CORPORATION) 141
TABLE 112 ASAHI KASEI CORPORATION: BUSINESS OVERVIEW 141
FIGURE 36 ASAHI KASEI CORPORATION: COMPANY SNAPSHOT (2022) 142
10.1.2 BECTON, DICKINSON AND COMPANY 144
TABLE 113 BECTON, DICKINSON AND COMPANY: BUSINESS OVERVIEW 144
FIGURE 37 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2022) 145
10.1.3 GENTHERM INCORPORATED 147
TABLE 114 GENTHERM INCORPORATED: BUSINESS OVERVIEW 147
FIGURE 38 GENTHERM INCORPORATED: COMPANY SNAPSHOT (2022) 148
10.1.4 STRYKER CORPORATION 150
TABLE 115 STRYKER CORPORATION: BUSINESS OVERVIEW 150
FIGURE 39 STRYKER CORPORATION: COMPANY SNAPSHOT (2022) 151
10.1.5 BELMONT MEDICAL TECHNOLOGIES 153
TABLE 116 BELMONT MEDICAL TECHNOLOGIES: BUSINESS OVERVIEW 153
10.1.6 INTERNATIONAL BIOMEDICAL LTD. 154
TABLE 117 INTERNATIONAL BIOMEDICAL LTD.: BUSINESS OVERVIEW 154
10.1.7 EM-MED 155
TABLE 118 EM-MED: BUSINESS OVERVIEW 155
10.1.8 PHOENIX MEDICAL SYSTEMS 156
TABLE 119 PHOENIX MEDICAL SYSTEMS: BUSINESS OVERVIEW 156
10.1.9 LIFE RECOVERY SYSTEMS 157
TABLE 120 LIFE RECOVERY SYSTEMS: BUSINESS OVERVIEW 157
10.1.10 SHENZHEN COMEN MEDICAL INSTRUMENTS CO., LTD. 158
TABLE 121 SHENZHEN COMEN MEDICAL INSTRUMENTS CO., LTD.: BUSINESS OVERVIEW 158
10.1.11 MIRACRADLE (PLUSS ADVANCED TECHNOLOGIES PVT. LTD.) 159
TABLE 122 MIRACRADLE: BUSINESS OVERVIEW 159
10.2 OTHER PLAYERS 160
10.2.1 TERUMO CARDIOVASCULAR SYSTEMS CORPORATION 160
TABLE 123 TERUMO CARDIOVASCULAR SYSTEMS CORPORATION: COMPANY OVERVIEW 160
10.2.2 PFM MEDICAL HICO GMBH 161
TABLE 124 PFM MEDICAL HICO GMBH: COMPANY OVERVIEW 161
10.2.3 VNG MEDICAL INNOVATION SYSTEM PVT. LTD. 161
TABLE 125 VNG MEDICAL INNOVATION SYSTEM PVT. LTD.: COMPANY OVERVIEW 161
10.2.4 ASPEN SYSTEMS 162
TABLE 126 ASPEN SYSTEMS: COMPANY OVERVIEW 162
10.2.5 COOLTECH MEDICAL 162
TABLE 127 COOLTECH MEDICAL: COMPANY OVERVIEW 162
10.2.6 GLOBAL HEALTHCARE SG 163
TABLE 128 GLOBAL HEALTHCARE SG: COMPANY OVERVIEW 163
10.2.7 CRYOTHERMIC SYSTEMS INCORPORATED 163
TABLE 129 CRYOTHERMIC SYSTEMS INCORPORATED: COMPANY OVERVIEW 163
10.2.8 PAXMAN COOLERS LTD. 164
TABLE 130 PAXMAN COOLERS LTD.: COMPANY OVERVIEW 164
10.2.9 DIGNITANA AB 164
TABLE 131 DIGNITANA AB: COMPANY OVERVIEW 164
10.2.10 WISHCAPS 165
TABLE 132 WISHCAPS: COMPANY OVERVIEW 165
*Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments might not be captured in case of unlisted companies.
11 APPENDIX 166
11.1 DISCUSSION GUIDE 166
11.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 170
11.3 CUSTOMIZATION OPTIONS 172
11.4 RELATED REPORTS 172
11.5 AUTHOR DETAILS 173



*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/



※注目の調査資料
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(MD8924-24 )"低体温療法装置の世界市場予測(~2028):製品別、用途別、地域別" (英文:Therapeutic Hypothermia Systems Market by Product (Cooling Devices, Cooling Catheters, Cool Caps), Application (Neurology, Cardiology, Neonatal Care), and Region (North America, Europe, Asia- Pacific, RoW) - Global Forecast to 2028)はMarketsandMarkets社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。